Announced
Rite Aid rejected a $3.6bn offer from Spear Point Capital.
Synopsis
Rite Aid, an American drugstore chain, rejected a $3.6bn offer from Spear Point Capital Management, a private equity firm. Rite Aid's board said the proposal was not credible as it had no evidence of financing and required multiple months of exclusivity, among other reasons.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.